Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI
Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round. Sources told Bloomberg today that the investment could be worth more than $2 billion. OpenAI Group PBC backer Thrive Capita...
SiliconANGLE
Source

Generated insight by OnAirToday AI
This significant funding round for Isomorphic Labs underscores the massive investment pouring into AI for drug discovery and development. Such substantial capital indicates a strong belief in AI's potential to accelerate the creation of life-saving therapies, which could revolutionize healthcare.
Get the day's AI news in one short email. Free.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.